Journal article
LTR retroelement expansion of the human cancer transcriptome and immunopeptidome revealed by de novo transcript assembly
- Abstract:
- Dysregulated endogenous retroelements (EREs) are increasingly implicated in the initiation, progression, and immune surveillance of human cancer. However, incomplete knowledge of ERE activity limits mechanistic studies. By using pan-cancer de novo transcript assembly, we uncover the extent and complexity of ERE transcription. The current assembly doubled the number of previously annotated transcripts overlapping with long-terminal repeat (LTR) elements, several thousand of which were expressed specifically in one or a few related cancer types. Exemplified in melanoma, LTR-overlapping transcripts were highly predictable, disease prognostic, and closely linked with molecularly defined subtypes. They further showed the potential to affect disease-relevant genes, as well as produce novel cancer-specific antigenic peptides. This extended view of LTR elements provides the framework for functional validation of affected genes and targets for cancer immunotherapy.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 6.3MB, Terms of use)
-
- Publisher copy:
- 10.1101/gr.248922.119
Authors
- Publisher:
- Cold Spring Harbor Laboratory Press
- Journal:
- Genome Research More from this journal
- Volume:
- 29
- Issue:
- 10
- Pages:
- 1578-1590
- Publication date:
- 2019-09-19
- Acceptance date:
- 2019-08-21
- DOI:
- EISSN:
-
1549-5469
- ISSN:
-
1088-9051
- Pmid:
-
31537638
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:1069061
- UUID:
-
uuid:80363878-ab5a-476e-bad9-5838361e9cea
- Local pid:
-
pubs:1069061
- Source identifiers:
-
1069061
- Deposit date:
-
2020-01-16
Terms of use
- Copyright date:
- 2019
- Notes:
-
© 2019 Attig et al. Published by Cold Spring Harbor Laboratory Press.
This article, published in Genome Research, is available under a Creative Commons License (Attribution 4.0 International), as described at http://creativecommons.org/licenses/by/4.0/.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record